{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2017-10-23T09%3A33%3A43.383Z&AnsweringBody.=Department+of+Health+and+Social+Care&answer.attachment.fileName=2020+10+22+PQs+105571-72+Bristow+attachment.xlsx", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2017-10-23T09%3A33%3A43.383Z&AnsweringBody.=Department+of+Health+and+Social+Care&answer.attachment.fileName=2020+10+22+PQs+105571-72+Bristow+attachment.xlsx", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2017-10-23T09%3A33%3A43.383Z&AnsweringBody.=Department+of+Health+and+Social+Care&answer.attachment.fileName=2020+10+22+PQs+105571-72+Bristow+attachment.xlsx&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&min-answer.questionFirstMinisteriallyCorrected.=2017-10-23T09%3A33%3A43.383Z&AnsweringBody.=Department+of+Health+and+Social+Care&answer.attachment.fileName=2020+10+22+PQs+105571-72+Bristow+attachment.xlsx", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2017-10-23T09%3A33%3A43.383Z&AnsweringBody.=Department+of+Health+and+Social+Care&answer.attachment.fileName=2020+10+22+PQs+105571-72+Bristow+attachment.xlsx", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2017-10-23T09%3A33%3A43.383Z&AnsweringBody.=Department+of+Health+and+Social+Care&answer.attachment.fileName=2020+10+22+PQs+105571-72+Bristow+attachment.xlsx", "items" : [{"_about" : "http://data.parliament.uk/resources/1244554", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1244554/answer", "answerText" : {"_value" : "

NHS England and NHS Improvement undertake regular monitoring of the demand and supply position for priority medicines including noradrenaline. A table showing this information is attached.<\/p>

We cannot make accurate projections of demand going forward. However, we have used the information regarding first wave usage to inform mitigations for a second wave, such as stockpiling.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "attachment" : {"_about" : "http://data.parliament.uk/resources/1244554/answer/attachment/1", "fileName" : {"_value" : "2020 10 22 PQs 105571-72 Bristow attachment.xlsx"} , "title" : "Noradrenaline demand and supply"} , "dateOfAnswer" : {"_value" : "2020-10-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1244554/answer/previousversion/57690", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} } , "questionFirstAnswered" : [{"_value" : "2020-10-28T16:09:55.227Z", "_datatype" : "dateTime"} ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2020-11-11T14:29:56.35Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-10-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Noradrenaline"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of trends in the use of noradrenaline throughout the NHS in England in each month of 2020.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4792", "label" : {"_value" : "Biography information for Paul Bristow"} } , "tablingMemberConstituency" : {"_value" : "Peterborough"} , "tablingMemberPrinted" : [{"_value" : "Paul Bristow"} ], "uin" : "105571"} , {"_about" : "http://data.parliament.uk/resources/1244555", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1244555/answer", "answerText" : {"_value" : "

NHS England and NHS Improvement undertake regular monitoring of the demand and supply position for priority medicines including noradrenaline. A table showing this information is attached.<\/p>

We cannot make accurate projections of demand going forward. However, we have used the information regarding first wave usage to inform mitigations for a second wave, such as stockpiling.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "attachment" : {"_about" : "http://data.parliament.uk/resources/1244555/answer/attachment/1", "fileName" : {"_value" : "2020 10 22 PQs 105571-72 Bristow attachment.xlsx"} , "title" : "Noradrenaline demand and supply"} , "dateOfAnswer" : {"_value" : "2020-10-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1244555/answer/previousversion/57691", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} } , "questionFirstAnswered" : [{"_value" : "2020-10-28T16:09:55.273Z", "_datatype" : "dateTime"} ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2020-11-11T14:29:47.863Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-10-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Noradrenaline"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he has made an estimate of demand for noradrenaline during the remainder of 2020-21.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4792", "label" : {"_value" : "Biography information for Paul Bristow"} } , "tablingMemberConstituency" : {"_value" : "Peterborough"} , "tablingMemberPrinted" : [{"_value" : "Paul Bristow"} ], "uin" : "105572"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }